Related Experiment Video
Updated: Oct 30, 2025

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment
Xiao-Jie Liang1, Rui-Ying Fu2, He-Nan Wang2
1First Clinical Medical College of Southern Medical University, Nanfang Hospital of Southern Medical University, Guangzhou 510515, China.
A new immune-related gene classifier accurately predicts survival in diffuse large B cell lymphoma (DLBCL). This tool offers better prognostic power than clinical data alone, aiding DLBCL diagnosis and treatment strategies.
Area of Science:
- Oncology
- Immunology
- Bioinformatics
Background:
- Diffuse large B cell lymphoma (DLBCL) is a complex cancer with varied outcomes.
- Identifying immune biomarkers is crucial for improving DLBCL diagnosis and prognosis.
Purpose of the Study:
- To develop a novel immune-related gene (IRG) classifier for predicting prognosis in DLBCL.
- To evaluate the classifier's predictive power compared to traditional clinical data.
Main Methods:
- Systematic search of DLBCL gene expression datasets (GEO database).
- Selection of immune-related genes (IRGs) and transcription factor (TF) targets.
- Construction of a prognostic classifier using Cox regression and LASSO analysis.
- Analysis of tumor microenvironment (TME) and immune infiltration (ESTIMATE, CIBERSORT).
- WGCNA for exploring molecular mechanisms.
Main Results:
- An 18-IRG classifier demonstrated significant predictive ability for DLBCL prognosis.
- High-risk scores correlated with poorer overall survival.
- The classifier outperformed clinical data in predicting three- and five-year survival (AUC).
- Differences in TME, immune infiltration, and transcriptional regulation explain survival discrepancies.
Conclusions:
- A novel prognostic IRG classifier offers strong predictive power for DLBCL.
- This classifier can guide further research into DLBCL pathogenesis and clinical treatment strategies.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024